This article is more than 5 years old. Information may no longer be current.

VIDEO: Ajay Kirtane, MD, SM, shares highlights from TCT 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — In this video exclusive, Ajay Kirtane, MD, SM, provides insight on the COAPT trial, the 30th anniversary of TCT and other highlights from TCT.

This year marks the 30th anniversary of the TCT meeting, which began with a few hundred people in Washington, D.C., and has since expanded greatly, in terms of attendance and excitement, Kirtane, who is a co-director of TCT and also a physician at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, told Cardiology Today’s Intervention. Also this year, TCT featured Interactive Training Workshops that offered attendees the opportunity for hand-on learning with comprehensive, interactive areas and workshops that focused on specific areas of interventional cardiology, from imaging to structural to endovascular and more.

Kirtane also highlights some of the late-breaking research presented at TCT 2018, including COAPT, a carefully conducted, rigorous trial, which showed benefit of the MitraClip (Abbott) in patients with HF and mitral regurgitation.

Watch the video for more.